Clinical Trials Directory

Trials / Unknown

UnknownNCT04048213

The Becoming of Children With Doose Syndrome

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Centre Hospitalier Universitaire, Amiens · Academic / Other
Sex
All
Age
1 Year – 6 Years
Healthy volunteers
Not accepted

Summary

Doose syndrome is a rare epileptic syndrome that can lead to learning difficulties and a poor quality of life. The goal of this study is to evaluate the evolution of epilepsy and its consequences on cognitive development and learning issues in children with Doose syndrome.

Detailed description

Doose syndrome is a rare epileptic syndrome beginning between ages two and five, characterized by myoclonic-astatic seizures which can be associated with myoclonic seizures, astatic seizures, absences and generalized tonic-clonic seizures. These seizures can be difficult to treat effectively and may lead to learning difficulties. During this study, parents of children with Doose syndrome will receive a questionnaire regarding learning disabilities, quality of life and epilepsy of their children.

Conditions

Interventions

TypeNameDescription
OTHERquestionnairequestionnaire send to the parents

Timeline

Start date
2019-08-01
Primary completion
2023-12-01
Completion
2023-12-01
First posted
2019-08-07
Last updated
2023-04-12

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04048213. Inclusion in this directory is not an endorsement.